Detalhe da pesquisa
1.
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
BMC Cancer
; 22(1): 629, 2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672690
2.
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
Oncologist
; 24(1): 110-116, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082492
3.
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line.
Lab Invest
; 96(10): 1128-37, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617402
4.
Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case Report.
Pediatr Blood Cancer
; 63(10): 1840-3, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245095
5.
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
Pediatr Blood Cancer
; 62(1): 40-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25251256
6.
Outcome of advanced, unresectable conventional central chondrosarcoma.
Cancer
; 120(20): 3159-64, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995550
7.
Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
Eur J Cancer
; 53: 171-80, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26765686
8.
Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013.
Clin Sarcoma Res
; 4: 11, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25126409
9.
Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment.
Clin Sarcoma Res
; 2(1): 5, 2012 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22587841